Lexicon Pharmaceuticals, Inc. SEC filings LXRX
Lexicon Pharmaceuticals, Inc. has 1,003 filings in SEC EDGAR's recent list, going back to Jan 8, 2010. Its latest annual report, Form ARS, was filed on Mar 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 5, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2026 | Nov 5, 2026 |
| EFFECT | Filing | Aug 14, 2026 | — |
| S-3 | Shelf registration | Aug 6, 2026 | — |
| S-8 | Employee stock plan registration | Aug 6, 2026 | — |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
|
May 6, 2026 | May 4, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change, Shareholder vote results
|
Apr 30, 2026 | Apr 30, 2026 |
| ARS | Annual report to shareholders | Mar 16, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Mar 16, 2026 | — |
| DEF 14A | Proxy statement | Mar 16, 2026 | Mar 16, 2026 |
| 10-K | Annual report | Mar 5, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 5, 2026 | Mar 5, 2026 |
| PRE 14A | Preliminary proxy statement | Feb 17, 2026 | Feb 17, 2026 |
| D | Filing | Feb 17, 2026 | — |
| FWP | Free writing prospectus | Feb 6, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Feb 2, 2026 | Jan 29, 2026 |
| 424B5 | Prospectus supplement | Feb 2, 2026 | — |
| FWP | Free writing prospectus | Jan 30, 2026 | — |
| FWP | Free writing prospectus | Jan 30, 2026 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Jan 29, 2026 | Jan 29, 2026 |
| 424B5 | Prospectus supplement | Jan 29, 2026 | — |
| 8-K |
Current report
Other events
|
Nov 10, 2025 | Nov 6, 2025 |
| 424B5 | Prospectus supplement | Nov 6, 2025 | — |
| 8-K |
Current report
Other events
|
Nov 6, 2025 | Nov 6, 2025 |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| S-8 | Employee stock plan registration | Aug 6, 2025 | — |
| 10-Q | Quarterly report | Aug 6, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2025 | Aug 6, 2025 |
| 8-K |
Current report
Other events
|
Jul 28, 2025 | Jul 23, 2025 |
| 8-K |
Current report
Other events
|
Jul 3, 2025 | Jul 3, 2025 |
| 8-K |
Current report
Material agreement, Shareholder vote results
|
Jun 3, 2025 | Jun 2, 2025 |
| 10-Q | Quarterly report | May 14, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 13, 2025 | May 13, 2025 |
| ARS | Annual report to shareholders | Apr 22, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 22, 2025 | — |
| DEF 14A | Proxy statement | Apr 22, 2025 | Apr 22, 2025 |
| 8-K |
Current report
Material agreement
|
Mar 28, 2025 | Mar 27, 2025 |
| PRE 14A | Preliminary proxy statement | Mar 25, 2025 | Mar 20, 2025 |
| 10-K | Annual report | Mar 7, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 6, 2025 | Mar 6, 2025 |
| 8-K |
Current report
Listing notice
|
Jan 7, 2025 | Jan 3, 2025 |
| 8-K |
Current report
Officer or director change
|
Jan 2, 2025 | Jan 2, 2025 |
| 8-K |
Current report
Exit or restructuring costs
|
Nov 22, 2024 | Nov 22, 2024 |
| 8-K |
Current report
Officer or director change
|
Nov 20, 2024 | Nov 19, 2024 |
| 10-Q | Quarterly report | Nov 13, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2024 | Nov 12, 2024 |
| 8-K |
Current report
Material agreement
|
Oct 16, 2024 | Oct 16, 2024 |
| 8-K |
Current report
Officer or director change
|
Sep 16, 2024 | Sep 13, 2024 |
| EFFECT | Filing | Aug 15, 2024 | — |
| CORRESP | Letter to the SEC | Aug 9, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 8, 2024 | — |
| S-3 | Shelf registration | Aug 2, 2024 | — |
| 10-Q | Quarterly report | Aug 2, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 1, 2024 | Aug 1, 2024 |
| 8-K |
Current report
Officer or director change
|
Jul 8, 2024 | Jul 3, 2024 |
| 8-K |
Current report
Material agreement
|
Jul 1, 2024 | Jun 28, 2024 |
| EFFECT | Filing | May 15, 2024 | — |
| CORRESP | Letter to the SEC | May 13, 2024 | — |
| S-3/A | Filing | May 10, 2024 | — |
| 8-K |
Current report
Unregistered share sale, Bylaw or fiscal year change, Shareholder vote results
|
May 10, 2024 | May 10, 2024 |
| 10-Q | Quarterly report | May 2, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 2, 2024 | May 2, 2024 |
| 8-K |
Current report
Officer or director change
|
Apr 29, 2024 | Apr 29, 2024 |
| UPLOAD | Letter from the SEC | Mar 29, 2024 | — |
| ARS | Annual report to shareholders | Mar 26, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Mar 26, 2024 | — |
| DEF 14A | Proxy statement | Mar 26, 2024 | Mar 25, 2024 |
| S-3 | Shelf registration | Mar 25, 2024 | — |
| 10-K | Annual report | Mar 25, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Mar 12, 2024 | Mar 12, 2024 |
| PRE 14A | Preliminary proxy statement | Mar 11, 2024 | Mar 11, 2024 |
| 8-K |
Current report
Material agreement, Results of operations, Unregistered share sale, Bylaw or fiscal year change, Regulation FD disclosure
|
Mar 11, 2024 | Mar 6, 2024 |
| 8-K |
Current report
Material agreement
|
Dec 29, 2023 | Dec 29, 2023 |
| 424B5 | Prospectus supplement | Dec 29, 2023 | — |
| 8-K |
Current report
Material agreement
|
Dec 29, 2023 | Dec 29, 2023 |
| 10-Q | Quarterly report | Nov 8, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2023 | Nov 8, 2023 |
| 8-K |
Current report
Officer or director change
|
Oct 11, 2023 | Oct 9, 2023 |
| S-8 | Employee stock plan registration | Aug 4, 2023 | — |
| 10-Q | Quarterly report | Aug 4, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 3, 2023 | Aug 3, 2023 |
| 8-K |
Current report
Officer or director change
|
Jul 31, 2023 | Jul 27, 2023 |
| 8-K |
Current report
Officer or director change
|
Jul 24, 2023 | Jul 18, 2023 |
| 8-K |
Current report
New debt, Unregistered share sale
|
Jun 28, 2023 | Jun 23, 2023 |
| D | Filing | Jun 20, 2023 | — |
| CT ORDER | Filing | Jun 9, 2023 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Jun 2, 2023 | May 31, 2023 |
| 424B5 | Prospectus supplement | Jun 2, 2023 | — |
| FWP | Free writing prospectus | Jun 1, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 31, 2023 | May 31, 2023 |
| FWP | Free writing prospectus | May 31, 2023 | — |
| 424B5 | Prospectus supplement | May 31, 2023 | — |
| 8-K/A |
Amended current report
Shareholder vote results
|
May 8, 2023 | Apr 27, 2023 |
| 10-Q | Quarterly report | May 4, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Material agreement
|
May 2, 2023 | May 1, 2023 |
| 8-K |
Current report
Results of operations
|
May 2, 2023 | May 2, 2023 |
| 8-K |
Current report
Material agreement, Shareholder vote results
|
Apr 27, 2023 | Apr 27, 2023 |
| DEFA14A | Additional proxy material | Mar 17, 2023 | — |
| DEF 14A | Proxy statement | Mar 17, 2023 | Mar 16, 2023 |
| 10-K | Annual report | Mar 3, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 2, 2023 | Mar 2, 2023 |
| 8-K |
Current report
New debt, Unregistered share sale
|
Jan 4, 2023 | Dec 30, 2022 |
| 10-Q | Quarterly report | Nov 9, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2022 | Nov 9, 2022 |
| 8-K |
Current report
Material agreement
|
Sep 2, 2022 | Aug 29, 2022 |
| D | Filing | Aug 3, 2022 | — |
| 10-Q | Quarterly report | Aug 3, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 2, 2022 | Aug 2, 2022 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
Jul 29, 2022 | Jul 27, 2022 |
| 424B5 | Prospectus supplement | Jul 29, 2022 | — |
| 424B5 | Prospectus supplement | Jul 27, 2022 | — |
| 8-K |
Current report
Other events
|
Jun 30, 2022 | Jun 29, 2022 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results
|
May 25, 2022 | May 20, 2022 |
| 10-Q | Quarterly report | May 5, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 5, 2022 | May 5, 2022 |
| DEF 14A | Proxy statement | Apr 8, 2022 | Apr 7, 2022 |
| DEFA14A | Additional proxy material | Apr 8, 2022 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
|
Mar 17, 2022 | Mar 17, 2022 |
| PRE 14A | Preliminary proxy statement | Mar 11, 2022 | Mar 11, 2022 |
| 10-K | Annual report | Mar 10, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Feb 28, 2022 | Feb 28, 2022 |
| 10-Q | Quarterly report | Nov 9, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2021 | Nov 3, 2021 |
| EFFECT | Filing | Sep 14, 2021 | — |
| CORRESP | Letter to the SEC | Sep 10, 2021 | — |
| 8-K |
Current report
Officer or director change
|
Sep 9, 2021 | Sep 3, 2021 |
| UPLOAD | Letter from the SEC | Aug 12, 2021 | — |
| S-8 | Employee stock plan registration | Aug 6, 2021 | — |
| S-3 | Shelf registration | Aug 6, 2021 | — |
| 10-Q | Quarterly report | Aug 6, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Officer or director change, Other events
|
Aug 2, 2021 | Jul 28, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 2, 2021 | Jul 30, 2021 |
| 8-K |
Current report
Results of operations
|
Jul 30, 2021 | Jul 30, 2021 |
| 8-K |
Current report
Officer or director change, Other events
|
Jul 30, 2021 | Jul 30, 2021 |
| 10-Q | Quarterly report | May 6, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations
|
May 6, 2021 | May 6, 2021 |
| 8-K |
Current report
Material agreement, Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results
|
May 3, 2021 | Apr 29, 2021 |
| 8-K |
Current report
Officer or director change
|
Apr 1, 2021 | Mar 29, 2021 |
| DEFA14A | Additional proxy material | Mar 19, 2021 | — |
| DEF 14A | Proxy statement | Mar 19, 2021 | Mar 19, 2021 |
| 10-K | Annual report | Mar 12, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Results of operations
|
Mar 10, 2021 | Mar 10, 2021 |
| PRE 14A | Preliminary proxy statement | Feb 19, 2021 | Feb 19, 2021 |
| 8-K |
Current report
Material agreement
|
Feb 12, 2021 | Feb 8, 2021 |
| 8-K |
Current report
Other events
|
Jan 14, 2021 | Jan 14, 2021 |
| 8-K |
Current report
Material agreement
|
Dec 18, 2020 | Dec 16, 2020 |
| 8-K |
Current report
Material agreement, Other events
|
Dec 11, 2020 | Dec 11, 2020 |
| 424B5 | Prospectus supplement | Dec 11, 2020 | — |
| 8-K |
Current report
Other events
|
Dec 11, 2020 | Dec 11, 2020 |
| 8-K |
Current report
Other events
|
Nov 17, 2020 | Nov 16, 2020 |
| 424B5 | Prospectus supplement | Oct 30, 2020 | — |
| 10-Q | Quarterly report | Oct 30, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Results of operations
|
Oct 29, 2020 | Oct 29, 2020 |
| 8-K |
Current report
Material agreement
|
Oct 22, 2020 | Oct 16, 2020 |
| 8-K |
Current report
Unregistered share sale
|
Sep 29, 2020 | Sep 25, 2020 |
| 8-K |
Current report
Unregistered share sale
|
Sep 24, 2020 | Sep 23, 2020 |
| 8-K |
Current report
Acquisition or sale of assets, Other events
|
Sep 11, 2020 | Sep 8, 2020 |
| 8-K |
Current report
Agreement ended
|
Sep 8, 2020 | Sep 3, 2020 |
| 8-K |
Current report
Exit or restructuring costs, Officer or director change
|
Aug 4, 2020 | Jul 29, 2020 |
| 8-K |
Current report
Material agreement, Other events
|
Jul 30, 2020 | Jul 29, 2020 |
| 8-K |
Current report
Results of operations
|
Jul 30, 2020 | Jul 30, 2020 |
| S-8 | Employee stock plan registration | Jul 29, 2020 | — |
| 10-Q | Quarterly report | Jul 29, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Material agreement
|
Jul 15, 2020 | Jul 10, 2020 |
| 8-K |
Current report
Agreement ended
|
May 29, 2020 | May 29, 2020 |
| 10-Q | Quarterly report | Apr 27, 2020 | Mar 31, 2020 |
| 8-K |
Current report
Material agreement, Shareholder vote results
|
Apr 27, 2020 | Apr 23, 2020 |
| 8-K |
Current report
Results of operations
|
Apr 27, 2020 | Apr 27, 2020 |
| DEFA14A | Additional proxy material | Apr 7, 2020 | — |
| DEFA14A | Additional proxy material | Mar 13, 2020 | — |
| DEF 14A | Proxy statement | Mar 13, 2020 | Mar 13, 2020 |
| 10-K | Annual report | Mar 12, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Results of operations
|
Mar 12, 2020 | Mar 9, 2020 |
| 8-K |
Current report
Material agreement
|
Jan 16, 2020 | Jan 16, 2020 |
| EFFECT | Filing | Nov 18, 2019 | — |
| CORRESP | Letter to the SEC | Nov 15, 2019 | — |
| UPLOAD | Letter from the SEC | Nov 14, 2019 | — |
| S-8 | Employee stock plan registration | Nov 7, 2019 | — |
| S-3 | Shelf registration | Nov 7, 2019 | — |
| 10-Q | Quarterly report | Nov 7, 2019 | Sep 30, 2019 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2019 | Nov 7, 2019 |
| 8-K |
Current report
Material agreement, Agreement ended
|
Sep 10, 2019 | Sep 10, 2019 |
| 10-Q | Quarterly report | Aug 1, 2019 | Jun 30, 2019 |
| 8-K |
Current report
Results of operations
|
Jul 31, 2019 | Jul 31, 2019 |
| 8-K |
Current report
Agreement ended
|
Jul 29, 2019 | Jul 25, 2019 |
| 10-Q | Quarterly report | May 1, 2019 | Mar 31, 2019 |
| 8-K |
Current report
Results of operations
|
May 1, 2019 | May 1, 2019 |
| CT ORDER | Filing | Apr 29, 2019 | — |
| 8-K |
Current report
Material agreement, Shareholder vote results
|
Apr 26, 2019 | Apr 25, 2019 |
| DEFA14A | Additional proxy material | Mar 15, 2019 | — |
| DEF 14A | Proxy statement | Mar 15, 2019 | Dec 31, 2018 |
| 10-K | Annual report | Mar 15, 2019 | Dec 31, 2018 |
| 8-K |
Current report
Results of operations
|
Mar 13, 2019 | Mar 13, 2019 |
| PRE 14A | Preliminary proxy statement | Feb 15, 2019 | Dec 31, 2018 |
| 10-Q | Quarterly report | Nov 1, 2018 | Sep 30, 2018 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- LXRX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- The Woodlands, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1062822
- Former names
- LEXICON PHARMACEUTICALS, INC./DE (until Dec 5, 2014); LEXICON GENETICS INC/TX (until Apr 2, 2007)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.